Philips Grows Image-Guided Intervention Focus With Spectranetics Buy

29 Jun 2017

In its second acquisition this month and fourth this year, Philips is buying US device maker Spectranetics Corp. for about $2bn to add laser atherectomy catheters to its vascular imaging line-up.

Royal Philips has signed a $2bn-deal to buy Spectranetics Corp., a US firm that specializes in developing laser atherectomy catheters for both coronary and peripheral indications, accelerating the firm's strategic expansion into image-guided therapy devices

This marks the firm's fourth acquisition so far this year (Also see "Philips Completes M&A Hat Trick With Neurodiagnostic...